Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical ...

A discovery in cardiac regeneration offers ew hope for the treatment of ischemic heart failure. Published in npj Regenerative ...

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

After transcatheter patent foramen ovale (PFO) closure, patients with nickel hypersensitivity were more likely to develop ...

Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...

Researchers at UT Southwestern Medical Center found that tenecteplase, a newer drug, is just as safe and effective as ...

There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.

The study, published March 12 in JAMA Network Open, compared the newly approved tenecteplase in a single quick injection to alteplase, the stroke treatment that has been used for decades and requires ...

Overall, though, the meta-analysis identified a reduction in ischemia—but not in hard outcomes—with early treatment.

But a study shows ... Breakthrough Cardiac Regeneration Research Offers Hope for the Treatment of Ischemic Heart Failure Mar. 7, 2025 — The discovery of a novel approach to promote cardiomyocyte ...

A recent health survey in Kathmandu has uncovered troubling numbers that reveal a growing health crisis among the city ...

BioCardia ®, Inc . [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the Japan Patent Office ...